John Gallagher Sells 431 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 431 shares of the firm’s stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $25.35, for a total value of $10,925.85. Following the completion of the sale, the chief operating officer owned 32,634 shares in the company, valued at approximately $827,271.90. This represents a 1.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trupanion Price Performance

NASDAQ:TRUP traded up $1.38 during midday trading on Wednesday, hitting $26.15. 463,321 shares of the stock were exchanged, compared to its average volume of 382,592. The company has a market capitalization of $1.14 billion, a price-to-earnings ratio of 44.32 and a beta of 1.39. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. Trupanion, Inc. has a one year low of $21.16 and a one year high of $57.00. The business has a 50-day moving average price of $23.72 and a two-hundred day moving average price of $28.17.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.04. The company had revenue of $384.05 million for the quarter, compared to analysts’ expectations of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same period last year, the firm earned ($0.03) EPS. Sell-side analysts predict that Trupanion, Inc. will post 0.54 EPS for the current year.

Hedge Funds Weigh In On Trupanion

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Parallel Advisors LLC grew its holdings in shares of Trupanion by 1,831.9% during the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after acquiring an additional 1,722 shares in the last quarter. Kemnay Advisory Services Inc. acquired a new stake in Trupanion during the fourth quarter valued at $64,000. Kelleher Financial Advisors purchased a new position in Trupanion in the third quarter valued at about $74,000. PNC Financial Services Group Inc. grew its stake in Trupanion by 21.7% in the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock valued at $116,000 after purchasing an additional 478 shares in the last quarter. Finally, Advisory Services Network LLC acquired a new position in Trupanion in the 3rd quarter worth about $160,000.

Wall Street Analyst Weigh In

Several research analysts have issued reports on TRUP shares. Cantor Fitzgerald decreased their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. Bank of America cut their price objective on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Stifel Nicolaus set a $28.00 target price on Trupanion in a report on Friday, June 26th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a research report on Monday, June 1st. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Trupanion currently has a consensus rating of “Hold” and a consensus target price of $41.50.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.